Pfizer's Hospira recalls 5 injectable drug lots due to report of leak, potential seal issues
After a report of leaking product, Pfizer’s Hospira unit is pulling five lots of sterile injectable medicines from distribution. The recall affects certain batches of the company’s buprenorphine hydrochloride (HCI) injection and its labetalol …